Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies

@article{Chen2018EffectOF,
  title={Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies},
  author={Tuo Chen and Quoqi Zhou and Dan Zhang and Feng Jiang and Jing Wu and Jin-Yong Zhou and Xiao-Zhi Zheng and Yugen Chen},
  journal={Journal of Crohn's and Colitis},
  year={2018},
  volume={12},
  pages={710–717}
}
Background Evidence concerning the effect of faecal microbiota transplantation [FMT] in Clostridium difficile infection [CDI] patients with inflammatory bowel disease [IBD] has not been firmly established. Therefore, we performed a systematic review and meta-analysis to evaluate FMT treatment outcomes in patients with IBD treated for CDI. Methods An electronic search of four databases was conducted until November 1, 2017. Cohort studies of FMT efficacy and safety in CDI patients with IBD were… 

Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease patients: a systematic review and meta-analysis.

FMT is an effective and safe treatment for recurrent CDI in patients with IBD and should be considered early in cases of recurrent or refractory CDI.

An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis

A systematic review and meta-analysis to assess the efficiency and safety of FMT as a treatment for UC found that donor FMT might be more effective than placebo for attaining total remission and clinical response in patients with UC.

Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis

To improve the safety of IMT, patients' conditions should be fully evaluated before IMT , appropriate transplantation methods should be selected, each operative step of faecal bacteria transplantation should be strictly controlled, AE management mechanisms should be improved, and a close follow-up system should be established.

The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease

Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence

Compared with previous studies of FMT efficacy, this cohort had a lower primary cure rate and higher CDI recurrence rate than previously reported, likely driven by higher-risk subpopulations, and FMT should be considered early to prevent progression of CDI severity and recurrence.

Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort

The study supports the efficacy and safety of FMT in immunocompromised patients, though future research is needed to further ascertain the potential effects of immunosuppression on FMT outcomes.

Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT)

This Danish national guideline describes the treatment of adult patients with Clostridioides infection and the use of faecal microbiota transplantation (FMT) and suggests minimum standard for implementing an FMT service.

Cost‐effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease

Evaluated the potential health economic and clinical outcomes of four strategies for management of RCDI in IBD patients from the perspective of public health‐care provider in Hong Kong.

References

SHOWING 1-10 OF 53 REFERENCES

Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Fecal microbiota transplantation provides a good alternative treatment option with high success rates for recurrent or refractory Clostridium difficile infection in patients with well-controlled IBD who fail standard antimicrobial therapy.

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

The overall CDI cure rates were high, with a large percentage of patients experiencing clinical improvement of their IBD after FMT, and a minority of patients developed an IBD flare.

Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.

  • A. KhorutsKevin M. Rank M. Sadowsky
  • Medicine, Biology
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2016

P-198 YI Comparative Analysis of the Efficacy of Fecal Transplantation in Pediatric Inflammatory Bowel Disease Patients with and Without Clostridium Difficile Infection

There was a trend toward higher resolution of IBD flare inCDI+ patients than in CDI- patients, though it did not achieve statistical significance, and prospective, randomized trials may be warranted in a larger population.

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

  • S. Ben-HorinM. Margalit G. Moran
  • Medicine, Biology
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2009

The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission

Detection of C. difficile is increased in IBD outpatients in remission, and strain diversity is consistent with community acquisition from a multitude of sources.

Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

This series demonstrates the effective use of FMT for CDI in IC patients with few SAEs or related AEs, and there were no related infectious complications in these high-risk patients.

Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease

CD infection in patients with IBD results in a higher rate of recurrence and is associated with higher morbidity than the general population, suggesting that CD resulted in increased severity of IBD disease.

Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.

Fecal microbiota transplantation (FMT) consists in the infusion of the fecal suspension from a healthy donor into the gastrointestinal tract of a patient with CDI to restore the natural intestinal microflora and is safe and effective treatment of recurrent CDI.

Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease

It is shown that CDI patients with IBD have higher proportion of the original community after FMT and lack of improvement of their IBD symptoms and increased episodes of CDI on long-term follow-up, underscore the importance of the existing gut microbial landscape as a decisive factor to successfully treat CDI.
...